Arkolith/Insider Trading/ADIL/Form 4

Claiborne Cary J

Chief Executive Officer, DirectorADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Sep 20, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 20, 2022Grant(A)75K$0.42$32K1.1M
Sep 19, 2022Grant(A)25K$0.43$11K1.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-057513) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML